Trevi Therapeutics, Inc. - TRVI
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | President & CEO | A | A | 675,000.0 | 0.0 | 0.0 | 675,000.0 | View | |
| Feb 20, 2026 | Chief Commercial Officer | A | A | 160,000.0 | 0.0 | 0.0 | 160,000.0 | View | |
| Feb 20, 2026 | Chief Scientific Officer | A | A | 85,000.0 | 0.0 | 0.0 | 85,000.0 | View | |
| Feb 20, 2026 | See Remarks | A | A | 35,000.0 | 0.0 | 0.0 | 35,000.0 | View | |
| Feb 20, 2026 | Chief Development Officer | A | A | 215,000.0 | 0.0 | 0.0 | 215,000.0 | View | |
| Jan 12, 2026 | Chief Financial Officer | A | A | 375,000.0 | 0.0 | 0.0 | 375,000.0 | View | |
| Dec 03, 2025 | See Remarks | M | D | 4,225.0 | 0.0 | 0.0 | 15,775.0 | View | |
| Dec 03, 2025 | See Remarks | M | A | 4,225.0 | 0.511 | 2,158.98 | 26,095.0 | View |